Curaleaf Holdings, Inc. (CURLF) Form 10-Q — Nov 3, 2026
Curaleaf reported Q3 2026 revenue of $352.7 million, up 11% from $317.9 million a year earlier, but posted a net loss of $32.7 million ($0.12 per share) versus a $56.7 million loss in Q3 2025. Nine-month net income was $49.6 million, but that result was driven by a $123.0 million income tax benefit; the company ran a $77.8 million pre-tax loss for the nine months, weighed down by $51.3 million of interest expense on notes payable.
Key figures
- Revenue
- 352650000
- Revenue Yoy
- 11% (Q3 2026 vs Q3 2025: $352.65M vs $317.86M); nine-month revenue $1,017.0M vs $935.1M (+8.8%)
- Total Assets
- 2793135000
- Cash Position
- 92387000
- Shares Outstanding
- 264,996,138 (233,672,570 SVS + 31,323,568 MVS as of Oct 27, 2026)
- Goodwill
- 638287000
- Restricted cash
- 12546000
- Total revenue 9m
- 1016980000
- Reverse split ratio
- 1:3 (effected June 5, 2026)
- Gross profit q3 2026
- 170477000
- Cannabis haven acquisition
- $13.4M total consideration
- Operating cash flow 9m 2026
- 71343000
AI analysis
Red flags6 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.